New research from the University of Saskatchewan has scientists excited about the potential of a new therapy called acute intermittent hypoxia (AIH) for patients with partial spinal cord injuries. Continue ReadingRead More »
Machine learning is augmenting human ability and drastically changing possibilities. It is restructuring businesses and rewiring brains for transformative thinking. Whether it be to develop vaccines for deadly diseases or combat climate change, Canada is at the forefront of this monumental shift. Continue ReadingRead More »
BioNova is calling early-stage health and life science companies from Atlantic Canada for a chance to compete for $25,000 in seed funding and a $30,000 advisory services package to develop their business idea during BioPort 2018 on November 7-8, 2018 at the Halifax Convention Centre. Continue ReadingRead More »
Bioasis Technologies Inc. and BioAgilytix partner to strategically develop and validate bioanalytical methods to support and advance the xB3 TM-001 program, Bioasis’ lead candidate to treat HER2+ brain cancer, to investigational new drug (IND) submission and into the clinic. Continue ReadingRead More »
The new Ontario government has made some significant changes lately that will shape the future of the life sciences industry. With Molly Shoichet, the first and now former Chief Scientist of Ontario and Alan O’Dette, now the former Chief Investment Officer from the Ontario Investment Office being let go, it shines a light on the importance of having the industry’s voice heard.
Life sciences is an industry that is filled with innovation and offers significant economic promise for governments who desire to grow a knowledge-based economy. Canada is a world-class leader in this regard with a vast amount of companies ranging all over the sector that are on the forefront of monumental change.
The recent budget continues to invest in research so Canada can be globally competitive and be better aligned with supporting a 21st-century economy.
According to Finance Minister Bill Morneau, this budget represents the “largest investment in fundamental and discovery research in Canadian history”. Overall, Budget 2018 has proposed a substantial investment of nearly $4 billion in Canada’s research system. The government referenced the work of Canada’s Fundamental Science Review that led to these investments.
The Budget 2018 also highlighted supporting entrepreneurship and high potential businesses and added $540 million over the span of five years for the National Research Council with $108 million annually to strengthen its role with industry.
However, that being said, Doug Ford, the new Premier of Ontario proposes that there will be more budget slashing – to as much as $25 billion in the next three years – that could pose issues for this engaging and essential sector.
Biotechnology Focus has created a survey in support of Global Biotech Week (Sept. 24-30th) to showcase to the government the excellence that this sector strives for and how much potential it has in building a stronger ecosystem for Canada and its inhabitants. The results will be highlighted in a special report that will be released in our Innovation Issue coming out in August.
Add your voice to the Innovation report by taking this quick survey. The report will highlight trends, identify areas of strengths that can be leveraged as well as opportunities for improvement to support growth for the Canadian life sciences industry.